Home Tags Regeneron Pharmaceuticals

Tag: Regeneron Pharmaceuticals

Regeneron launches STEM teaching fellowship

New program will help teachers get their students interested in science, technology, engineering and math.

Nonprofits, businesses to volunteer on MLK Day

The Volunteer Center of United Way will partner with nonprofits and businesses to create 30 volunteer activities on Martin Luther King Day.

Regeneron gets $765K from state

The New York State Energy Research and Development Authority (NYSERDA) is giving $765,000 to Regeneron to help with the pharmaceutical company's energy efficiency products at its Tarrytown headquarters.

Eylea approved for use in Japan

Regeneron Pharmaceuticals Inc. announced today that Eylea was approved for the treatment of patients with neovascular, or wet, age-related macular degeneration (AMD) in Japan.

Regeneron cancer drug approved

The FDA approved Zaltrap to treat colorectal cancer, but asked for more data on a drug to treat gout.

Avon earnings plunge, profit for Regeneron, Jarden earnings double

High costs sank Avon’s earnings, while sales of Regeneron’s treatment for macular degeneration returned the company to profitability.

Zaltrap granted priority review by FDA

Zaltrap, currently in clinical trials after being developed by Regeneron Pharmaceuticals Inc. and Sanofi, has been granted priority review by the FDA.

Two up, one down in biotech earnings

Two biotech companies in Westchester report increased earnings in 2011, while the county’s largest biotech employer had greater losses.